Portage Biotech (PRTG) Short Interest Ratio & Short Volume → At first glance, this chart looks like nonsense… (From The TradingPub) (Ad) Free PRTG Stock Alerts $0.25 +0.01 (+4.16%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Portage Biotech Short Interest DataCurrent Short Volume6,500 sharesPrevious Short Volume15,400 sharesChange Vs. Previous Month-57.79%Dollar Volume Sold Short$3,661.45Short Interest Ratio / Days to Cover0.1Last Record DateMarch 31, 2024Outstanding Shares17,800,000 sharesFloat Size8,670,000 sharesShort Percent of Float0.07%Today's Trading Volume181,096 sharesAverage Trading Volume139,546 sharesToday's Volume Vs. Average130% Short Selling Portage Biotech ? Sign up to receive the latest short interest report for Portage Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPRTG Short Interest Over TimePRTG Days to Cover Over TimePRTG Percentage of Float Shorted Over Time Ad Insiders ExposedThe Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.Click To Access This Powerful Training Right Now! Portage Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20246,500 shares $3,661.45 -57.8%0.1%0.1 $0.56 3/15/202415,400 shares $8,470.00 -84.6%0.2%0.2 $0.55 2/29/2024100,200 shares $59,118.00 +902.0%1.2%1.8 $0.59 2/15/202410,000 shares $6,005.00 -9.1%0.1%0.2 $0.60 1/31/202411,000 shares $9,571.10 +44.7%0.1%0.3 $0.87 1/15/20247,600 shares $8,208.00 +16.9%0.1%0.2 $1.08 Get the Latest News and Ratings for PRTG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Portage Biotech and its competitors with MarketBeat's FREE daily newsletter. 12/31/20236,500 shares $11,830.00 -63.1%0.1%0.2 $1.82 12/15/202317,600 shares $22,352.00 -25.4%0.2%0.5 $1.27 11/30/202323,600 shares $31,034.00 -56.4%0.3%0.8 $1.32 11/15/202354,100 shares $78,445.00 +4.4%0.7%2 $1.45 10/31/202351,800 shares $102,823.00 -8.3%0.6%2.3 $1.99 10/15/202356,500 shares $119,780.00 +4.2%0.7%2.5 $2.12 9/30/202354,200 shares $113,278.00 +32.2%0.7%2.9 $2.09 9/15/202341,000 shares $118,490.00 +494.2%0.5%2.9 $2.89 8/31/20236,900 shares $17,664.00 -27.4%0.1%0.5 $2.56 8/15/20239,500 shares $22,800.00 +30.1%0.1%0.7 $2.40 7/31/20237,300 shares $23,506.00 +1.4%0.1%0.5 $3.22 7/15/20237,200 shares $24,408.00 +22.0%0.1%0.5 $3.39 6/30/20235,900 shares $20,591.00 -24.4%0.1%0.4 $3.49 6/15/20237,800 shares $28,860.00 -1.3%0.1%0.4 $3.70 5/31/20237,900 shares $27,492.00 -75.8%0.1%0.3 $3.48 5/15/202332,600 shares $104,646.00 -10.4%0.4%1.3 $3.21 4/30/202336,400 shares $121,576.00 -34.8%0.5%1.3 $3.34 4/15/202355,800 shares $175,770.00 +5.5%0.7%1.7 $3.15 3/31/202352,900 shares $163,461.00 +32.6%0.7%1.5 $3.09 3/15/202339,900 shares $119,700.00 -6.8%0.5%1.1 $3.00 2/28/202342,800 shares $163,496.00 -9.1%0.5%1.1 $3.82 2/15/202347,100 shares $198,762.00 -3.1%0.4%1.3 $4.22 1/31/202348,600 shares $250,290.00 +7.5%0.4%1.4 $5.15 1/15/202345,200 shares $246,150.16 -11.2%0.3%1.7 $5.45 12/30/202250,900 shares $269,261.00 +7.4%0.4%2.1 $5.29 12/15/202247,400 shares $237,000.00 -0.8%0.4%2.3 $5.00 11/30/202247,800 shares $281,064.00 +2.6%0.4%2.6 $5.88 11/15/202246,600 shares $280,066.00 +2.4%0.4%3.2 $6.01 10/31/202245,500 shares $298,935.00 -23.1%0.3%3.2 $6.57 10/15/202259,200 shares $400,192.00 +11.1%0.9%3.9 $6.76 9/30/202253,300 shares $363,506.00 +1.0%0.8%3.3 $6.82 9/15/202252,800 shares $414,480.00 -23.6%0.8%2 $7.85 8/31/202269,100 shares $532,761.00 +0.4%1.4%2.3 $7.71 8/15/202268,800 shares $580,672.00 -12.1%1.4%1.9 $8.44The Hard Truth About Investing For Retirement (Ad)Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.Click To Access This Powerful Training Right Now! PRTG Short Interest - Frequently Asked Questions What is Portage Biotech's current short interest? Short interest is the volume of Portage Biotech shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 6,500 shares of PRTG short. 0.07% of Portage Biotech's shares are currently sold short. Learn More on Portage Biotech's current short interest. What is a good short interest percentage for Portage Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.07% of Portage Biotech's floating shares are currently sold short. Is Portage Biotech's short interest increasing or decreasing? Portage Biotech saw a decrease in short interest in March. As of March 31st, there was short interest totaling 6,500 shares, a decrease of 57.8% from the previous total of 15,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Portage Biotech's float size? Portage Biotech currently has issued a total of 17,800,000 shares. Some of Portage Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Portage Biotech currently has a public float of 8,670,000 shares. How does Portage Biotech's short interest compare to its competitors? 0.07% of Portage Biotech's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Portage Biotech: ZyVersa Therapeutics, Inc. (8.09%), Helius Medical Technologies, Inc. (8.53%), Lipella Pharmaceuticals Inc. (1.24%), Cingulate Inc. (1.21%), Artelo Biosciences, Inc. (0.45%), Genprex, Inc. (3.78%), TRACON Pharmaceuticals, Inc. (32.74%), Soligenix, Inc. (1.10%), Tharimmune, Inc. (0.65%), Seelos Therapeutics, Inc. (5.82%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Portage Biotech stock? Short selling PRTG is an investing strategy that aims to generate trading profit from Portage Biotech as its price is falling. PRTG shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Portage Biotech? A short squeeze for Portage Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PRTG, which in turn drives the price of the stock up even further. How often is Portage Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRTG, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: ZVSA Short Squeeze HSDT Short Squeeze LIPO Short Squeeze CING Short Squeeze ARTL Short Squeeze GNPX Short Squeeze TCON Short Squeeze SNGX Short Squeeze THAR Short Squeeze SEEL Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PRTG) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyPrepare for a recession unlike any otherAmerican Hartford Gold GroupRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Crypto for 2024InvestorPlace